NIH cancels mRNA vaccine contracts
>In the article, Bhattacharya called the mRNA platform a “promising technology” and acknowledged that it may lead to breakthroughs in treatment for diseases like cancer.
>“But as a vaccine intended for broad public use, especially during a public health emergency, the platform has failed a crucial test: earning public trust,” he wrote.
>“No matter how elegant the science, a platform that lacks credibility among the people it seeks to protect cannot fulfill its public health mission.”
>He blamed public distrust in mRNA on the Biden administration’s COVID-19 vaccine mandates during the pandemic.
>“Science isn’t propaganda,” Bhattacharya wrote in the op-ed. “It’s humility. And when public health officials stopped communicating with humility, we lost much of the public, an absolute necessity for any vaccine platform.”
https://archive.is/olBCN
>“But as a vaccine intended for broad public use, especially during a public health emergency, the platform has failed a crucial test: earning public trust,” he wrote.
>“No matter how elegant the science, a platform that lacks credibility among the people it seeks to protect cannot fulfill its public health mission.”
>He blamed public distrust in mRNA on the Biden administration’s COVID-19 vaccine mandates during the pandemic.
>“Science isn’t propaganda,” Bhattacharya wrote in the op-ed. “It’s humility. And when public health officials stopped communicating with humility, we lost much of the public, an absolute necessity for any vaccine platform.”
https://archive.is/olBCN
